Due to the systemic effects of metabolic disorders, NAFLD pathology impairs lipid metabolism and insulin sensitivity, increases oxidative stress and systemic inflammation, exacerbates liver lipid deposition, and cardiovascular complications [9, 10]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.